FDA moves to pull approval of Tavneos, saying it was based on manipulated study data

Summary

The FDA wants to withdraw its approval of the drug Tavneos. The regulator says the drug was approved on the basis of manipulated study data. The reporting raises the question of whether patients should still have access to it. This summary is drawn only from the article's headline and feed summary, not its full text.

Timeline

1. Ars Technica

   31 Oct 2026, 11:02 UTCSource ↗

   Reports that the FDA wants to pull its approval of Tavneos, saying the drug was approved on the basis of manipulated study data, and asks whether patients should still have access to it.